<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Visual impairment in adults: Refractive disorders and presbyopia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Visual impairment in adults: Refractive disorders and presbyopia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Visual impairment in adults: Refractive disorders and presbyopia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shahzad I Mian, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Matthew F Gardiner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Givens, MD, MSCE</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Refractive errors and presbyopia are common, correctable causes of impaired vision throughout the world.</p><p>The normal eye creates a clear image by bending (refracting) light in order to focus it onto the retina. Refractive errors occur when a component of the eye's optical system fails to focus the optical image. Presbyopia ("aging sight") is a non-refractive error that also affects visual acuity. Presbyopia occurs when the lens loses its normal accommodating power and can no longer focus on objects viewed at arm's length or closer.</p><p>This topic will cover the epidemiology, diagnosis, and treatment of refractive errors and presbyopia in adults. Refractive errors in children and laser refractive treatment are discussed separately. (See  <a class="medical medical_review" href="/d/html/6260.html" rel="external">"Refractive errors in children"</a> and  <a class="medical medical_review" href="/d/html/6908.html" rel="external">"Laser refractive surgery"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">FUNCTIONAL ANATOMY OF THE EYE</span><span class="headingEndMark"> — </span>The eye's ability to focus is dependent on the eye's optical system, which consists of two refractive surfaces working in tandem: the cornea and the crystalline lens  (<a class="graphic graphic_figure graphicRef59910" href="/d/graphic/59910.html" rel="external">figure 1</a>).</p><p>The refractive power of the eye and of corrective lenses is measured in diopters, where a diopter is the reciprocal of the focal length measured in meters. The focal length is the distance from a lens to its focus or focal point.</p><p>The cornea is the more powerful refractive element, accounting for two-thirds of the eye's refractive power. The lens provides the remaining one-third, for a total refractive power of 60 diopters (D).</p><p>The cornea has a fixed amount of refractive power while the lens can vary its power by altering its shape [<a href="#rid1">1</a>]. Accommodation is the term used to describe this change in lens shape, which can increase the power of the lens to enable the eye to focus on objects at arm's length or closer.</p><p class="headingAnchor" id="H447055264"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Refractive errors are a developmental disorder. There are causes of adult-onset refractive errors, such as cataracts, diabetes, and alteration in shape of the eye, which are not discussed in this section. The developing eye in childhood through early adulthood maintains focus on the retina by a process known as emmetropization. This process involves detection of a blurred image on the retina with subsequent diffusion of signals into the outer layers of the eye, including the choroid and sclera  (<a class="graphic graphic_figure graphicRef59910" href="/d/graphic/59910.html" rel="external">figure 1</a>). This results in alteration of the size of the eye in order to maintain clear vision throughout development [<a href="#rid2">2</a>]. Emmetropization is accomplished by modulating scleral growth and choroidal thickness. With refractive errors, the emmetropization process goes awry for reasons that remain largely unknown.</p><p>Cellular and/or physiologic mechanisms are thought to cause retinal defocusing with resulting altered axial length and myopia during the developmental process. In addition, eye growth is sensitive to an individual's visual experience. The mechanisms thought to cause retinal defocusing include [<a href="#rid3">3,4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Form deprivation, which can lead to alterations in the ocular lens system, with elongation of the visual axis</p><p class="bulletIndent1"><span class="glyph">●</span>Excessive accommodation</p><p class="bulletIndent1"><span class="glyph">●</span>Scleral stretching (secondary to increased intraocular pressure)</p><p class="bulletIndent1"><span class="glyph">●</span>Autonomic deficits during accommodation</p><p></p><p class="headingAnchor" id="H3"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>Emmetropia (normal refraction) describes the refractive state in which parallel light rays emanating from an object located 20 feet or more from the eye form a focused image on the retina of an eye that has not accommodated.  (<a class="graphic graphic_figure graphicRef81157" href="/d/graphic/81157.html" rel="external">figure 2</a> and <a class="graphic graphic_movie graphicRef79812" href="/d/graphic/79812.html" rel="external">movie 1</a>). Ametropia refers to the refractive state in which the image is not focused on the retina.</p><p class="headingAnchor" id="H4237494664"><span class="h2">Abnormal refraction (ametropia)</span><span class="headingEndMark"> — </span>Refractive disorders are ametropic states in which the eye is unable to bring light rays emanating from an object viewed from a distance into clear focus on the retina, without the aid of a refractive device (eg, spectacles, contact lenses). Myopia, hyperopia, and astigmatism are the three ametropic states. They are caused by abnormalities in the axial length (distance from the posterior corneal surface to the retina) of the eye or in the shape of the cornea.</p><p class="headingAnchor" id="H6"><span class="h3">Myopia</span><span class="headingEndMark"> — </span>Myopia ("nearsightedness") is a common refractive disorder in which the axial length of the eye is either too long or the refractive power of the eye's optical system is too great (generally due to corneal protrusion resulting in steep corneal curvature). The image is focused in front of the retina  (<a class="graphic graphic_figure graphicRef65268" href="/d/graphic/65268.html" rel="external">figure 3</a> and <a class="graphic graphic_movie graphicRef69617" href="/d/graphic/69617.html" rel="external">movie 2</a>). This results in blurred distance vision unless optical correction is achieved with a refractive device. A refractive device can provide a more concave surface which reduces the excessive focusing power of the eye's optical system  (<a class="graphic graphic_movie graphicRef80691" href="/d/graphic/80691.html" rel="external">movie 3</a>).</p><p class="headingAnchor" id="H7"><span class="h3">Hyperopia</span><span class="headingEndMark"> — </span>Hyperopia ("farsightedness") is a refractive disorder in which the axial length of the eye is too short or the power of the eye's optical system is insufficient (due to a flat cornea) to produce a focused image on the retina. The image is focused behind the retina  (<a class="graphic graphic_figure graphicRef75265" href="/d/graphic/75265.html" rel="external">figure 4</a> and <a class="graphic graphic_movie graphicRef72862" href="/d/graphic/72862.html" rel="external">movie 4</a>). Hyperopia is corrected with a refractive device that provides a more convex refracting surface in order to increase the deficient focusing power of the eye's optical system  (<a class="graphic graphic_movie graphicRef51690" href="/d/graphic/51690.html" rel="external">movie 5</a>).</p><p class="headingAnchor" id="H8"><span class="h3">Astigmatism</span><span class="headingEndMark"> — </span>Astigmatism ("lack of a pinpoint" in Greek) refers to the refractive condition in which a warped corneal surface causes light rays entering the eye along different planes to be focused unevenly  (<a class="graphic graphic_movie graphicRef61074" href="/d/graphic/61074.html" rel="external">movie 6</a>). The patient reports blurred vision at all viewing distances. Unlike myopia and hyperopia, which are corrected by spectacles containing a spherical surface, astigmatism is corrected by spectacles containing a cylindrical optical surface  (<a class="graphic graphic_movie graphicRef68083" href="/d/graphic/68083.html" rel="external">movie 7</a>). A spherical lens is a device with optical symmetry which can either converge or scatter light rays, while a cylindrical lens does not have optical symmetry. One meridian (a closed curve on the surface of a sphere) in the cylindrical lens is more curved than the opposite meridian. Soft (toric) or rigid gas permeable contact lenses can also be used to correct astigmatism. Contact lenses are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6906.html" rel="external">"Overview of contact lenses"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Presbyopia</span><span class="headingEndMark"> — </span>Presbyopia ("aging sight") is a type of refractive error related to loss of accommodation in the aging lens such that it can no longer focus on objects viewed at arm's length or closer.</p><p>In youth, the eye is able to easily accommodate or increase the curvature of the lens by contracting the ciliary muscle  (<a class="graphic graphic_figure graphicRef59910" href="/d/graphic/59910.html" rel="external">figure 1</a>). The ciliary muscle surrounds the lens and is connected to it by zonular fibers. The normally taut zonular fibers stretch the lens and keep it from assuming a fully rounded state. The desire to focus on reading material automatically stimulates ciliary smooth muscle contraction, which loosens the zonular fibers and allows the lens to become more rounded. In the fully rounded state, the lens provides the additional refractive power needed to bring reading material into focus.</p><p>During the natural aging process, the crystalline lens loses its elasticity and therefore its ability to become more rounded when the zonular fibers loosen their grip. Presbyopia usually begins after age 40 when patients start to appreciate the inability to focus on objects at reading distance. In patients with presbyopia, the eye's focusing power for reading is lost progressively and fully by age 65 years.</p><p class="headingAnchor" id="H11"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The prevalence and risk factors associated with myopia are well-described. The epidemiologic data for other refractive errors have been less studied.</p><p class="headingAnchor" id="H12"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>Refractive disorders are common, affecting approximately one-third of persons age ≥40 years in the United States and Western Europe [<a href="#rid5">5</a>]. Worldwide, a total of 123 million people are estimated to be visually impaired from uncorrected refractive errors, of whom approximately four million are blind (as defined by best-corrected visual acuity &lt;20/400) [<a href="#rid6">6</a>].</p><p>Prevalence rates vary depending on the type of refractive error, with myopia and astigmatism being the most common.</p><p class="bulletIndent1"><span class="glyph">●</span>Myopia – The global prevalence of myopia was estimated at 23 percent in 2000 and is increasing [<a href="#rid7">7</a>], including in the United States and Europe [<a href="#rid8">8,9</a>]. In the United States, the prevalence of myopia from between 1971 and 1972 to between 1999 and 2004 nearly doubled among persons age 12 to 54 years (25 versus 42 percent) [<a href="#rid8">8</a>]. In Europe, myopia prevalence is higher among more recent birth decades; age-standardized myopia prevalence is 18 percent in those born between 1910 and 1939 compared with 23.5 percent among those born between 1940 and 1979 [<a href="#rid9">9</a>]. This difference, in part, may reflect changes in education and consequent demands for close-up tasks such as reading, population shifts, and changes in the classification of myopia. (See <a class="local">'Risk factors'</a> below.)</p><p></p><p class="bulletIndent1">The prevalence of myopia decreases with increasing age, from about 40 percent in adults age 20 to 59 years to about 20 percent in adults age ≥60 years [<a href="#rid10">10</a>]. The decrease in myopia may be secondary to progressive cataract formation. In contrast to childhood-onset myopia where the degree of myopia tends to worsen rapidly, the degree of myopia stabilizes in late adolescence and is subject to a slow rate of myopic change after age 20.</p><p></p><p class="bulletIndent1">Prevalence rates of myopia also vary by race and ethnicity. In the United States, White Americans have the highest rates of myopia, followed by African Americans, then Hispanic Americans [<a href="#rid10">10</a>]. Worldwide, the prevalence of myopia is especially high among Asian persons [<a href="#rid11">11-13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperopia – In contrast to myopia, the prevalence of hyperopia increases with age, from 1 to 2 percent in those age 20 to 59 years to 10 percent in those age ≥60 years [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Astigmatism – Similar to hyperopia, the prevalence of astigmatism increases with age from approximately 25 percent among adults age 20 to 59 to 50 percent among adults age ≥60 years [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Presbyopia – It is estimated that, in 2015, there were 1.8 billion people with presbyopia worldwide. Approximately 826 million of those had uncorrected or undercorrected vision [<a href="#rid14">14</a>]. In the United States, presbyopia is the most common cause of visual impairment due to aging of the "baby boomer" generation, the 76 million Americans born between 1946 and 1964 [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H13"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>There are several different risk factors for myopia which have been well-documented [<a href="#rid16">16-33</a>], whereas less data are available for other refractive errors [<a href="#rid34">34-36</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Myopia</strong> — The development of myopia is associated with higher education levels and intelligence test scores, as well as occupations requiring close-up tasks of high accommodative demand (eg, reading, writing, computer work) [<a href="#rid37">37</a>]. Known causes include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Genetic – Multiple studies have shown that hereditary factors are associated with the development of myopia [<a href="#rid16">16,17</a>]. Lack of complete concordance between myopia and monozygotic twins, as well as between generations in families, suggests a polygenic inheritance model with influence of gene-environment effects [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reading – An association in children between myopia and prolonged reading or reading at close range is well-documented [<a href="#rid18">18,19</a>]. Continuous hyperopic defocusing that occurs during prolonged periods of reading may lead the emmetropization mechanism to increase the axial length of the eye, leading to myopia [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Medications – Myopia can develop rapidly following use of certain medications. Sulfa-derived medications (eg, sulfamethoxazole, <a class="drug drug_general" data-topicid="10006" href="/d/drug information/10006.html" rel="external">topiramate</a>) and diuretics (eg, <a class="drug drug_general" data-topicid="8482" href="/d/drug information/8482.html" rel="external">furosemide</a>, <a class="drug drug_general" data-topicid="9268" href="/d/drug information/9268.html" rel="external">acetazolamide</a>) can induce transient myopia through forward displacement and thickening of the lens by relaxation of the zonules [<a href="#rid21">21</a>]. Cholinergic medications (eg, <a class="drug drug_general" data-topicid="9693" href="/d/drug information/9693.html" rel="external">neostigmine</a>, <a class="drug drug_general" data-topicid="9772" href="/d/drug information/9772.html" rel="external">pilocarpine</a>) can also result in accommodative spasm with subsequent transient myopia. Withdrawal of the medication usually results in complete resolution of myopia [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Diabetes mellitus – Transient refractive changes in patients with diabetes mellitus are well-documented [<a href="#rid23">23,24</a>]. Alterations in serum osmolarity secondary to changes in blood glucose levels can cause an influx of osmotic fluid into the lens with subsequent lens swelling and a transient increase in refractive power or myopia. As a result, patients with type I or type II diabetes often present with transient blurred vision, particularly those with poorly controlled glucose.</p><p></p><p class="bulletIndent2">The prevalence of myopia is higher in diabetic patients compared with non-diabetic patients [<a href="#rid25">25</a>]. Patients with diabetes who have poorly controlled hemoglobin A1C are also more likely to have myopia due to lenticular changes.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Trauma – Ocular trauma can cause forward displacement of the lens with subsequent myopia.</p><p></p><p class="bulletIndent2">Scleral laceration repair and use of scleral encircling elements in retinal detachment repair can temporarily deform the globe, inducing astigmatism and myopia. In cases where this deformation continues postoperatively, the increased axial length leads to persistent myopia [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Excessive accommodation – Patients with pathologically excessive accommodation may have "accommodative spasm." The symptoms may include double vision and myopia. Anxiety and patient behaviors (forced excessive convergence by focusing on a near object) are common causes, but traumatic brain injury and parasympathomimetic medications can also lead to excessive accommodation [<a href="#rid27">27,28</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increased intraocular pressure – Although the rate of myopia progression may be associated with increased intraocular pressure [<a href="#rid29">29</a>], data from the Correction of Myopia Evaluation Trial have shown no correlation between intraocular pressure and myopic progression [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maternal factors – Myopia is associated with greater maternal age at birth and maternal smoking during pregnancy [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Light exposure – The role of light exposure in the development of myopia is unclear. After adjusting for confounders, children who spend more time in outdoor activities have a lower prevalence of myopia [<a href="#rid31">31,40,41</a>]. Persons who are near-sighted have higher serum melatonin levels, suggesting a role for light exposure and circadian rhythm in the myopic growth mechanism [<a href="#rid42">42</a>]. Results are mixed as to whether night lights (dim light left on during sleep) are associated with development of myopia [<a href="#rid32">32,33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperopia</strong> — Several risk factors may lead to a posterior shift of the crystalline lens or shortening of the eye's axial length and result in hyperopia. These include ocular trauma, mass effect of an orbital tumor posterior to the retina, scleral inflammation with subretinal thickening, and surgical removal of the crystalline lens without replacing it with a synthetic intraocular lens.</p><p></p><p class="bulletIndent1">Anticholinergic medications (eg, <a class="drug drug_general" data-topicid="9728" href="/d/drug information/9728.html" rel="external">oxybutynin</a>, <a class="drug drug_general" data-topicid="9915" href="/d/drug information/9915.html" rel="external">scopolamine</a>) exert parasympatholytic effects on the ciliary muscle, decreasing accommodation and inducing hyperopia. Patients treated for hyperglycemia who have a rapid decrease in blood glucose levels experience transient hyperopia that can last for several weeks [<a href="#rid34">34,35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Astigmatism</strong> — Risk factors for astigmatism are largely unknown but may be related to genetic and/or developmental factors [<a href="#rid36">36</a>].</p><p></p><p class="headingAnchor" id="H16"><span class="h1">CLINICAL CONSEQUENCES</span></p><p class="headingAnchor" id="H4178818420"><span class="h2">Daily functioning</span><span class="headingEndMark"> — </span>Several observational studies have shown that refractive errors are associated with limitations in instrumental activities of daily living (IADLs), falls, decreased ability to drive or work, and depression [<a href="#rid43">43-47</a>]. In one cohort study of noninstitutionalized older adult subjects, visual impairment was associated with limitations in ADLs, one-fifth of which were estimated to be preventable by use of best optical correction [<a href="#rid43">43</a>].</p><p>Although visual correction may improve ability to read and perform other tasks, it does not appear to reduce risk or rate of falls among older adults. In one randomized trial, visual correction including new eyeglasses, glaucoma management, and cataract surgery led to an increased rate of falls compared with usual care [<a href="#rid48">48</a>], possibly related to an adjustment period needed to adapt to new corrective eyeglasses, and a less sedentary lifestyle.</p><p class="headingAnchor" id="H17"><span class="h2">Associated eye disorders</span><span class="headingEndMark"> — </span>Refractive errors have also been associated with other ocular pathology [<a href="#rid49">49-54</a>].</p><p>High degrees of refractive error (myopia &gt;6.0 diopters [D], hyperopia &gt;3.0 D, astigmatism &gt;3.0 D) are associated with pathologic ocular changes [<a href="#rid49">49</a>]. Highly myopic patients have an increased incidence of retinal thinning, peripheral retinal degeneration, retinal detachment [<a href="#rid50">50</a>], cataract [<a href="#rid51">51</a>], and glaucoma [<a href="#rid52">52,53</a>]. Among patients with myopic refractive errors of 1 to 3 D, more than half of non-traumatic retinal detachments are attributable to myopia [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/d/html/6910.html" rel="external">"Retinal detachment"</a> and  <a class="medical medical_review" href="/d/html/6904.html" rel="external">"Cataract in adults"</a> and  <a class="medical medical_review" href="/d/html/6909.html" rel="external">"Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6903.html" rel="external">"Angle-closure glaucoma"</a>.)</p><p>Hyperopia is associated with ocular pathology but to a lesser extent than myopia. Hyperopia is associated with angle-closure glaucoma, age-related macular degeneration, and cataracts [<a href="#rid54">54,55</a>]. (See  <a class="medical medical_review" href="/d/html/6901.html" rel="external">"Age-related macular degeneration"</a>.)</p><p class="headingAnchor" id="H18"><span class="h1">SCREENING AND DIAGNOSTIC TESTS</span><span class="headingEndMark"> — </span>There is no consensus on how and when to perform routine screening of visual acuity. Different organizations have different recommendations:</p><p class="bulletIndent1"><span class="glyph">●</span>The US Preventive Services Task Force states that there is <strong>insufficient evidence</strong> to assess the benefits and harms of screening for impaired vision in adults aged 65 and older without vision problems [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Canadian Task Force on the Periodic Health Examination recommends<strong> against</strong> screening in primary care settings for impaired vision in community-dwelling adults aged 65 and older without risk factors for impaired vision [<a href="#rid57">57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The American Academy of Ophthalmology (AAO) recommends comprehensive eye examinations by ophthalmologists for adults with no symptoms or risk factors [<a href="#rid58">58</a>], although there is little evidence supporting this recommendation.</p><p></p><p>Visual screening tests are recommended in children, which is discussed separately. (See  <a class="medical medical_review" href="/d/html/6261.html" rel="external">"Vision screening and assessment in infants and children", section on 'Vision screening'</a>.)</p><p>There are a variety of visual charts to examine visual acuity, although few data are available showing superiority of one method over another [<a href="#rid59">59</a>]. The Snellen eye chart is considered one of the clinical standards for evaluating visual acuity and can be used in the primary care setting  (<a class="graphic graphic_figure graphicRef50810" href="/d/graphic/50810.html" rel="external">figure 5</a>) [<a href="#rid60">60</a>]. Patients should have their vision examined at 20 feet and while reading. While there is no explicit evidence regarding appropriate cutoffs for referral, patients with unexplained vision loss in either eye should be referred to an eye specialist for further evaluation.</p><p>Although refractive errors may be suspected on history of visual blurriness or by visual acuity testing, diagnosis of all refractive disorders is confirmed with use of a phoropter by the eye specialist. A phoropter is an instrument containing different lenses used to bring the focus of objects onto the retina  (<a class="graphic graphic_picture graphicRef66741" href="/d/graphic/66741.html" rel="external">picture 1</a>). In addition to diagnosis, a phoropter is also used to measure severity of refractive error for prescribing corrective lenses. Automated devices may also allow assessment of refractive errors which may provide a technological advancement in addressing global blindness [<a href="#rid61">61</a>].</p><p>A retinoscope and pinhole occluder are additional devices that can be used to assess refractive error by an eye specialist. A retinoscope is an objective measure of refractive error that is not dependent upon patient response  (<a class="graphic graphic_picture graphicRef55046" href="/d/graphic/55046.html" rel="external">picture 2</a>). The retinoscope projects a beam of light into the patient's eye through the pupil. Through the peephole in the scope, the observer sees a light reflex coming from the patient's pupil. By observing the behavior of the reflex under certain conditions, the observer can objectively determine the refractive error of the patient's eye.</p><p>A pinhole occluder may also be used as a screening tool for refractive errors  (<a class="graphic graphic_picture graphicRef66325" href="/d/graphic/66325.html" rel="external">picture 3</a>). The occluder is a simple way to focus light, as in a pinhole camera, temporarily removing the effects of refractive errors such as myopia. Because light passes only through the center of the eye's lens, defects in the shape of the lens (errors of refraction) have no effect while the occluder is used. This can allow estimation of the maximum improvement in a patient's vision that can be attained by lenses to correct errors of refraction. Squinting works similarly to a pinhole occluder, by blocking light through the outer parts of the eye's lens.</p><p class="headingAnchor" id="H19"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>The decision to treat refractive disorders depends on the individual patient's symptoms and needs. Treatment is aimed to improve visual acuity, visual comfort (eg, visual distortion, polycoria, decreased stereopsis), and other visual function (eg, color discrimination, motion detection, peripheral vision).</p><p>First-line treatments include corrective lenses, such as glasses and contact lenses, or refractive surgery.</p><p class="headingAnchor" id="H20"><span class="h2">Corrective lenses</span><span class="headingEndMark"> — </span>Corrective lenses work by altering the overall power of the lens system of the eye. Concave lenses for myopia act to weaken the lens system, or reduce its power in diopters. Convex lenses for hyperopia act by strengthening the lens system, or increasing its power in diopters. Cylindrical lenses are used to correct astigmatism.</p><p>Presbyopia is treated with use of convex lenses as "reading glasses" or in combination with a correction for distance viewing in which the lenses may be lined (bifocals, trifocals) or unlined (multifocals, progressive).</p><p>Spectacles, or glasses, are the most common method of treating refractive errors, followed by contact lenses. (See  <a class="medical medical_review" href="/d/html/6906.html" rel="external">"Overview of contact lenses"</a>.)</p><p>Overnight contact lens use (orthokeratology) and low-dose <a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">atropine</a> in children may be effective in slowing progression of mild to moderate degrees of myopia [<a href="#rid62">62,63</a>].</p><p class="headingAnchor" id="H21"><span class="h3">Interpreting the prescription</span><span class="headingEndMark"> — </span>By convention, lenses that increase divergence and decrease the eye's focusing power are considered "minus" lenses; lenses that increase convergence and increase focusing power are considered "plus" lenses. Accordingly, myopic refractive error is corrected with concave ("minus", "divergent") lenses  (<a class="graphic graphic_movie graphicRef80691" href="/d/graphic/80691.html" rel="external">movie 3</a>), and hyperopia is corrected with convex ("plus", "convergent") lenses  (<a class="graphic graphic_movie graphicRef51690" href="/d/graphic/51690.html" rel="external">movie 5</a>). Astigmatism is corrected by cylindrical lenses which even out the eye's focusing power  (<a class="graphic graphic_movie graphicRef68083" href="/d/graphic/68083.html" rel="external">movie 7</a>).</p><p>In spectacle prescription notation, the first number is the refractive power, also known as the sphere. A minus number indicates a concave lens; a plus number indicates a convex lens. The second number denotes the cylinder, which corrects any astigmatic component. The "x" that follows the astigmatism power denotes the axis (in radial degrees) of the cylinder. Spectacle prescriptions are then written in increments of 0.25 diopters (D). For example, a prescription for a patient with myopia and astigmatism may read -4.50 + 2.50 x 090 and a prescription for a patient with hyperopia and astigmatism may read +3.25 + 1.50 x 180.</p><p>OD signifies the right eye (oculus dexter in Latin). OS signifies the left eye (oculus sinister). OU signifies both eyes (oculi uterque).</p><p class="headingAnchor" id="H22"><span class="h2">Surgical correction</span><span class="headingEndMark"> — </span>The most common surgical procedure performed to correct refractive errors is laser in situ keratomileusis (LASIK). Overall outcomes with LASIK are favorable, leading to rapid recovery of vision and minimal pain after surgery. Other corneal surgical procedures include photorefractive keratectomy (PRK), and laser epithelial keratomileusis (LASEK). Laser refractive procedures are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/6908.html" rel="external">"Laser refractive surgery"</a>.)</p><p>Intraocular lens implants, similar to those used to correct vision with cataract surgery, can correct high degrees of myopia. However, intraocular lens implants can result in cataract formation, increased intraocular pressure, and damage to the cornea over time. Thus, lens implants are not routinely recommended for correction of refractive errors.</p><p class="headingAnchor" id="H4202102144"><span class="h2">Eye drops: Pilocarpine</span><span class="headingEndMark"> — </span>A modified ophthalmic solution of <a class="drug drug_general" data-topicid="9772" href="/d/drug information/9772.html" rel="external">pilocarpine</a> hydrochloride is available in the United States for treatment of presbyopia in adults ages 40 to 55 [<a href="#rid64">64</a>]. Pilocarpine causes constriction of the pupil, resulting in an increase in the depth of field and improvement in near and intermediate visual acuity. The onset of effect occurs within 15 minutes and last for up to six hours. Headache is the most common side effect, and patients may experience difficulty changing focus from near vision to distance vision. There is also a small increased risk of retinal tears and retinal detachment, especially in patients with pre-existing retinal disease, and examination of the retina prior to treatment initiation should be considered [<a href="#rid65">65</a>]. Patients should be advised to avoid driving at night or performing other hazardous tasks in poorly illuminated spaces while the drug is active.</p><p>Evidence for efficacy comes from two trials, GEMINI-1 and GEMINI-2, in which <a class="drug drug_general" data-topicid="9772" href="/d/drug information/9772.html" rel="external">pilocarpine</a> resulted in improved ability to read at low light compared with placebo [<a href="#rid66">66,67</a>]. Although no cases of retinal tears or detachments were reported in the trials, rare cases of retinal detachment have been reported with other miotics when used in susceptible individuals and those with preexisting retinal disease. Patients should be advised to seek immediate medical care with sudden onset of vision loss [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H12804756"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15850.html" rel="external">"Patient education: Age-related vision loss (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/15845.html" rel="external">"Patient education: Open-angle glaucoma (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/16331.html" rel="external">"Patient education: Presbyopia and refractive errors (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Refractive errors occur when a component of the eye's optical system fails to focus an optical image onto the retina. The optical system consists of two refractive surfaces working in tandem: the cornea and the crystalline lens  (<a class="graphic graphic_figure graphicRef59910" href="/d/graphic/59910.html" rel="external">figure 1</a>). (See <a class="local">'Functional anatomy of the eye'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Refractive errors include myopia (nearsightedness), hyperopia (farsightedness), astigmatism (abnormal corneal shape), and presbyopia (aging sight). (See <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormalities in refraction are common, affecting one-third of persons age ≥40 years in the United States and Western Europe. Worldwide, uncorrected refractive errors are a common cause of poor visual acuity and blindness. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of visual acuity in the primary care setting can be performed with a standard Snellen chart. Patients with visual acuity less than 20/25 in either eye have impaired visual acuity and should be referred to an eye specialist for further evaluation. (See <a class="local">'Screening and diagnostic tests'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treatments for refractive errors include glasses, contact lenses, and refractive surgery. (See <a class="local">'Treatment'</a> above and  <a class="medical medical_review" href="/d/html/6908.html" rel="external">"Laser refractive surgery"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Subcommittee AAoOBaCS. Section 3: Clinical Optics. San Francisco, CA: American Academy of Ophthalmology, 2008.</li><li><a class="nounderline abstract_t">Lawrence MS, Azar DT. Myopia and models and mechanisms of refractive error control. Ophthalmol Clin North Am 2002; 15:127.</a></li><li><a class="nounderline abstract_t">Wallman J, Winawer J. Homeostasis of eye growth and the question of myopia. Neuron 2004; 43:447.</a></li><li><a class="nounderline abstract_t">Chen JC, Schmid KL, Brown B. The autonomic control of accommodation and implications for human myopia development: a review. Ophthalmic Physiol Opt 2003; 23:401.</a></li><li><a class="nounderline abstract_t">Kempen JH, Mitchell P, Lee KE, et al. The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol 2004; 122:495.</a></li><li><a class="nounderline abstract_t">Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012; 96:614.</a></li><li><a class="nounderline abstract_t">Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 2016; 123:1036.</a></li><li><a class="nounderline abstract_t">Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol 2009; 127:1632.</a></li><li><a class="nounderline abstract_t">Williams KM, Bertelsen G, Cumberland P, et al. Increasing Prevalence of Myopia in Europe and the Impact of Education. Ophthalmology 2015; 122:1489.</a></li><li><a class="nounderline abstract_t">Vitale S, Ellwein L, Cotch MF, et al. Prevalence of refractive error in the United States, 1999-2004. Arch Ophthalmol 2008; 126:1111.</a></li><li><a class="nounderline abstract_t">Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 2008; 86:63.</a></li><li><a class="nounderline abstract_t">McCarty CA, Livingston PM, Taylor HR. Prevalence of myopia in adults: implications for refractive surgeons. J Refract Surg 1997; 13:229.</a></li><li><a class="nounderline abstract_t">Krishnaiah S, Srinivas M, Khanna RC, Rao GN. Prevalence and risk factors for refractive errors in the South Indian adult population: The Andhra Pradesh Eye disease study. Clin Ophthalmol 2009; 3:17.</a></li><li><a class="nounderline abstract_t">Fricke TR, Tahhan N, Resnikoff S, et al. Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling. Ophthalmology 2018; 125:1492.</a></li><li><a class="nounderline abstract_t">Rosenbloom AA Jr. New aged and old aged: impact of the Baby Boomer. Optometry 2003; 74:211.</a></li><li><a class="nounderline abstract_t">Dirani M, Chamberlain M, Shekar SN, et al. Heritability of refractive error and ocular biometrics: the Genes in Myopia (GEM) twin study. Invest Ophthalmol Vis Sci 2006; 47:4756.</a></li><li><a class="nounderline abstract_t">Dirani M, Shekar SN, Baird PN. Evidence of shared genes in refraction and axial length: the Genes in Myopia (GEM) twin study. Invest Ophthalmol Vis Sci 2008; 49:4336.</a></li><li><a class="nounderline abstract_t">Saw SM, Chua WH, Hong CY, et al. Nearwork in early-onset myopia. Invest Ophthalmol Vis Sci 2002; 43:332.</a></li><li><a class="nounderline abstract_t">Ip JM, Saw SM, Rose KA, et al. Role of near work in myopia: findings in a sample of Australian school children. Invest Ophthalmol Vis Sci 2008; 49:2903.</a></li><li><a class="nounderline abstract_t">Mutti DO, Mitchell GL, Hayes JR, et al. Accommodative lag before and after the onset of myopia. Invest Ophthalmol Vis Sci 2006; 47:837.</a></li><li><a class="nounderline abstract_t">Bovino JA, Marcus DF. The mechanism of transient myopia induced by sulfonamide therapy. Am J Ophthalmol 1982; 94:99.</a></li><li><a class="nounderline abstract_t">Drug-induced myopia. Prescrire Int 2003; 12:22.</a></li><li><a class="nounderline abstract_t">Duke-Elder WS. CHANGES IN REFRACTION IN DIABETES MELLITUS. Br J Ophthalmol 1925; 9:167.</a></li><li><a class="nounderline abstract_t">Fledelius HC, Fuchs J, Reck A. Refraction in diabetics during metabolic dysregulation, acute or chronic. With special reference to the diabetic myopia concept. Acta Ophthalmol (Copenh) 1990; 68:275.</a></li><li><a class="nounderline abstract_t">Jacobsen N, Jensen H, Lund-Andersen H, Goldschmidt E. Is poor glycaemic control in diabetic patients a risk factor of myopia? Acta Ophthalmol 2008; 86:510.</a></li><li class="breakAll">Trobe JD. Symptoms of Optical Disorders. In: Neurology of Vision, 1st ed, Oxford University Press, New York 2001.</li><li><a class="nounderline abstract_t">Goldstein JH, Schneekloth BB. Spasm of the near reflex: a spectrum of anomalies. Surv Ophthalmol 1996; 40:269.</a></li><li><a class="nounderline abstract_t">Tijssen CC, Goor C, Van Woerkom TC. Spasm of the near reflex: functional or organic disorder. Neuro-ophthalmology 1983; 3:59.</a></li><li><a class="nounderline abstract_t">Mitchell P, Hourihan F, Sandbach J, Wang JJ. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999; 106:2010.</a></li><li><a class="nounderline abstract_t">Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol 1983; 118:213.</a></li><li><a class="nounderline abstract_t">Rose KA, Morgan IG, Ip J, et al. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology 2008; 115:1279.</a></li><li><a class="nounderline abstract_t">Saw SM, Wu HM, Hong CY, et al. Myopia and night lighting in children in Singapore. Br J Ophthalmol 2001; 85:527.</a></li><li><a class="nounderline abstract_t">Saw SM, Zhang MZ, Hong RZ, et al. Near-work activity, night-lights, and myopia in the Singapore-China study. Arch Ophthalmol 2002; 120:620.</a></li><li><a class="nounderline abstract_t">Furushima M, Imaizumi M, Nakatsuka K. Changes in refraction caused by induction of acute hyperglycemia in healthy volunteers. Jpn J Ophthalmol 1999; 43:398.</a></li><li><a class="nounderline abstract_t">Lin SF, Lin PK, Chang FL, Tsai RK. Transient hyperopia after intensive treatment of hyperglycemia in newly diagnosed diabetes. Ophthalmologica 2009; 223:68.</a></li><li><a class="nounderline abstract_t">Read SA, Collins MJ, Carney LG. A review of astigmatism and its possible genesis. Clin Exp Optom 2007; 90:5.</a></li><li><a class="nounderline abstract_t">Saw SM, Katz J, Schein OD, et al. Epidemiology of myopia. Epidemiol Rev 1996; 18:175.</a></li><li><a class="nounderline abstract_t">Tedja MS, Haarman AEG, Meester-Smoor MA, et al. IMI - Myopia Genetics Report. Invest Ophthalmol Vis Sci 2019; 60:M89.</a></li><li><a class="nounderline abstract_t">Rahi JS, Cumberland PM, Peckham CS. Myopia over the lifecourse: prevalence and early life influences in the 1958 British birth cohort. Ophthalmology 2011; 118:797.</a></li><li><a class="nounderline abstract_t">McKnight CM, Sherwin JC, Yazar S, et al. Myopia in young adults is inversely related to an objective marker of ocular sun exposure: the Western Australian Raine cohort study. Am J Ophthalmol 2014; 158:1079.</a></li><li><a class="nounderline abstract_t">Morgan IG, Wu PC, Ostrin LA, et al. IMI Risk Factors for Myopia. Invest Ophthalmol Vis Sci 2021; 62:3.</a></li><li><a class="nounderline abstract_t">Kearney S, O'Donoghue L, Pourshahidi LK, et al. Myopes have significantly higher serum melatonin concentrations than non-myopes. Ophthalmic Physiol Opt 2017; 37:557.</a></li><li><a class="nounderline abstract_t">Daien V, Pérès K, Villain M, et al. Visual impairment, optical correction, and their impact on activity limitations in elderly persons: the POLA study. Arch Intern Med 2011; 171:1206.</a></li><li><a class="nounderline abstract_t">Klein BE, Klein R, Lee KE, Cruickshanks KJ. Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology 1998; 105:160.</a></li><li><a class="nounderline abstract_t">Ivers RQ, Mitchell P, Cumming RG. Sensory impairment and driving: the Blue Mountains Eye Study. Am J Public Health 1999; 89:85.</a></li><li><a class="nounderline abstract_t">Sherrod CE, Vitale S, Frick KD, Ramulu PY. Association of vision loss and work status in the United States. JAMA Ophthalmol 2014; 132:1239.</a></li><li><a class="nounderline abstract_t">Hong T, Mitchell P, Burlutsky G, et al. Visual impairment and depressive symptoms in an older Australian cohort: longitudinal findings from the Blue Mountains Eye Study. Br J Ophthalmol 2015; 99:1017.</a></li><li><a class="nounderline abstract_t">Cumming RG, Ivers R, Clemson L, et al. Improving vision to prevent falls in frail older people: a randomized trial. J Am Geriatr Soc 2007; 55:175.</a></li><li><a class="nounderline abstract_t">Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt 2005; 25:381.</a></li><li><a class="nounderline abstract_t">Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group. Am J Epidemiol 1993; 137:749.</a></li><li><a class="nounderline abstract_t">Lim R, Mitchell P, Cumming RG. Refractive associations with cataract: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 1999; 40:3021.</a></li><li><a class="nounderline abstract_t">Grødum K, Heijl A, Bengtsson B. Refractive error and glaucoma. Acta Ophthalmol Scand 2001; 79:560.</a></li><li><a class="nounderline abstract_t">Wong TY, Klein BE, Klein R, et al. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology 2003; 110:211.</a></li><li><a class="nounderline abstract_t">Ikram MK, van Leeuwen R, Vingerling JR, et al. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2003; 44:3778.</a></li><li><a class="nounderline abstract_t">Verhoeven VJ, Wong KT, Buitendijk GH, et al. Visual consequences of refractive errors in the general population. Ophthalmology 2015; 122:101.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force (USPSTF), Siu AL, Bibbins-Domingo K, et al. Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2016; 315:908.</a></li><li><a class="nounderline abstract_t">Wilson BJ, Courage S, Bacchus M, et al. Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings. CMAJ 2018; 190:E588.</a></li><li><a class="nounderline abstract_t">Feder RS, Olsen TW, Prum BE Jr, et al. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern(®) Guidelines. Ophthalmology 2016; 123:P209.</a></li><li><a class="nounderline abstract_t">Chou R, Dana T, Bougatsos C, et al. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2016; 315:915.</a></li><li><a class="nounderline abstract_t">Kniestedt C, Stamper RL. Visual acuity and its measurement. Ophthalmol Clin North Am 2003; 16:155.</a></li><li><a class="nounderline abstract_t">Perches S, Collados MV, Ares J. Repeatability and Reproducibility of Virtual Subjective Refraction. Optom Vis Sci 2016; 93:1243.</a></li><li><a class="nounderline abstract_t">Lee YC, Wang JH, Chiu CJ. Effect of Orthokeratology on myopia progression: twelve-year results of a retrospective cohort study. BMC Ophthalmol 2017; 17:243.</a></li><li><a class="nounderline abstract_t">Gong Q, Janowski M, Luo M, et al. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis. JAMA Ophthalmol 2017; 135:624.</a></li><li><a class="nounderline abstract_t">Vuity - pilocarpine ophthalmic solution for presbyopia. Med Lett Drugs Ther 2022; 64:17.</a></li><li class="breakAll">Vuity (pilocarpine hydrochloride ophthalmic solution). US FDA approved product information: Allergen; August 2022. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214028s001lbl.pdf (Accessed on August 18, 2022).</li><li><a class="nounderline abstract_t">Waring GO 4th, Price FW Jr, Wirta D, et al. Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial. JAMA Ophthalmol 2022; 140:363.</a></li><li class="breakAll">Waring GO, McCabe C, Wirta D, et al. GEMINI 1 &amp; 2 pooled phase 3 safety and efficacy: AGN-190584 primary and key secondary endpoints. Paper presentation, American Academy of Ophthalmology Annual Meeting, New Orleans, LA November 2021.</li><li class="breakAll">VUITY - pilocarpine hydrochloride solution/drops. US Food and Drug Administration (FDA) approved product information. Revised October 2021. US National Library of Medicine. Available online at https://www.dailymed.nlm.nih.gov/dailymed/ (Accessed on March 20, 2022).</li></ol></div><div id="topicVersionRevision">Topic 6895 Version 47.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Subcommittee AAoOBaCS. Section 3: Clinical Optics. San Francisco, CA: American Academy of Ophthalmology, 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12064076" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Myopia and models and mechanisms of refractive error control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15312645" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Homeostasis of eye growth and the question of myopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12950887" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The autonomic control of accommodation and implications for human myopia development: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15078666" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The prevalence of refractive errors among adults in the United States, Western Europe, and Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22133988" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Global estimates of visual impairment: 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26875007" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20008719" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25983215" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Increasing Prevalence of Myopia in Europe and the Impact of Education.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18695106" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Prevalence of refractive error in the United States, 1999-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18235892" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Global magnitude of visual impairment caused by uncorrected refractive errors in 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9183754" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prevalence of myopia in adults: implications for refractive surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19668540" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prevalence and risk factors for refractive errors in the South Indian adult population: The Andhra Pradesh Eye disease study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29753495" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12703684" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : New aged and old aged: impact of the Baby Boomer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17065484" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Heritability of refractive error and ocular biometrics: the Genes in Myopia (GEM) twin study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18552384" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Evidence of shared genes in refraction and axial length: the Genes in Myopia (GEM) twin study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11818374" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Nearwork in early-onset myopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18579757" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Role of near work in myopia: findings in a sample of Australian school children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16505015" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Accommodative lag before and after the onset of myopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6979937" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The mechanism of transient myopia induced by sulfonamide therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12602401" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Drug-induced myopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18168468" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : CHANGES IN REFRACTION IN DIABETES MELLITUS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2392902" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Refraction in diabetics during metabolic dysregulation, acute or chronic. With special reference to the diabetic myopia concept.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18081906" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Is poor glycaemic control in diabetic patients a risk factor of myopia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18081906" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Is poor glycaemic control in diabetic patients a risk factor of myopia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8658338" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Spasm of the near reflex: a spectrum of anomalies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Spasm of the near reflex: functional or organic disorder</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10519600" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The relationship between glaucoma and myopia: the Blue Mountains Eye Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6881127" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Senile macular degeneration: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18294691" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Outdoor activity reduces the prevalence of myopia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11316706" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Myopia and night lighting in children in Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12003612" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Near-work activity, night-lights, and myopia in the Singapore-China study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10580662" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Changes in refraction caused by induction of acute hyperglycemia in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19023224" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Transient hyperopia after intensive treatment of hyperglycemia in newly diagnosed diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17177660" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A review of astigmatism and its possible genesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9021311" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Epidemiology of myopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30817828" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : IMI - Myopia Genetics Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21185080" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Myopia over the lifecourse: prevalence and early life influences in the 1958 British birth cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25072831" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Myopia in young adults is inversely related to an objective marker of ocular sun exposure: the Western Australian Raine cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33909035" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : IMI Risk Factors for Myopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28721695" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Myopes have significantly higher serum melatonin concentrations than non-myopes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21482828" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Visual impairment, optical correction, and their impact on activity limitations in elderly persons: the POLA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9442793" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9987472" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Sensory impairment and driving: the Blue Mountains Eye Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25032668" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Association of vision loss and work status in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25722491" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Visual impairment and depressive symptoms in an older Australian cohort: longitudinal findings from the Blue Mountains Eye Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17302652" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Improving vision to prevent falls in frail older people: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16101943" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Myopia and associated pathological complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8484366" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10549667" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Refractive associations with cataract: the Blue Mountains Eye Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11782219" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Refractive error and glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12511368" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Refractive errors, intraocular pressure, and glaucoma in a white population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12939291" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25208857" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Visual consequences of refractive errors in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26934260" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29759965" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26581558" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern(®) Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26934261" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12809155" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Visual acuity and its measurement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27391538" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Repeatability and Reproducibility of Virtual Subjective Refraction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29216865" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effect of Orthokeratology on myopia progression: twelve-year results of a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28494063" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35134046" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Vuity - pilocarpine ophthalmic solution for presbyopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35134046" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Vuity - pilocarpine ophthalmic solution for presbyopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35238902" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
